Evidence map›Paper›PMID 35576512›Full record

ArticleClinical and experimental immunology2022

Increased levels of pathogenic Th17 cells and diminished function of CD69+ Treg lymphocytes in patients with overweight.

Alejandra Mendoza-Pérez, Marlen Vitales-Noyola, Larisa González-Baranda, Crisol Álvarez-Quiroga, Berenice Hernández-Castro, Adriana Monsiváis-Urenda, Lourdes Baranda, Perla Niño-Moreno, Gilberto Hurtado, Raquel Sánchez-Gutiérrez and 1 more

Abstract read
In one paragraph

Article in Clinical and experimental immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alejandra Mendoza-PérezSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Marlen Vitales-NoyolaSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Larisa González-BarandaSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Crisol Álvarez-QuirogaSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Berenice Hernández-CastroSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Adriana Monsiváis-UrendaSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Lourdes BarandaSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Perla Niño-MorenoSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Gilberto HurtadoHospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, SLP, México.
Raquel Sánchez-GutiérrezSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.
Roberto González-AmaroSection of Molecular and Translational Medicine, Research Center of Health Sciences and Biomedicine (CICSaB), UASLP, San Luis Potosí, SLP, México.ORCID 0000-0001-6025-7375

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A low-grade inflammatory phenomenon is a feature of overweight and metabolic syndrome. The involvement of a pro-inflammatory Th17 lymphocyte subset and the CD69+ T regulatory (Treg) cell subtype in patients with metabolic dysfunction associated with or without overweight has not been fully elucidated. The aim of this study was to perform a quantitative and functional analysis of pathogenic Th17 lymphocytes and CD69+ Treg cells in patients with metabolic dysfunction (insulin resistance and dyslipidemia). The number of pathogenic Th17 cells and the levels and function of CD69+ Treg cells were analyzed in blood samples from individuals with metabolic dysfunction, associated with or without overweight. Pathogenic and non-pathogenic Th17 lymphocytes as well as Th22 cells were determined by eight-color flow cytometry analysis, whereas the levels and suppressive function of CD69+ Treg cells were also analyzed by multiparametric flow cytometry. We detected increased levels of pro-inflammatory Th17 pathogenic cells and Th22 lymphocytes in overweight unhealthy individuals (P < 0.001, compared to normal weight healthy). Conversely, diminished numbers of CD69+ Treg lymphocytes were observed in metabolically unhealthy individuals, with or without overweight. Likewise, the immunosuppressive function of CD69+ Treg cells was also defective in these patients. The increased levels of pathogenic Th17 cells along with a diminished number and function of CD69+ Treg lymphocytes may significantly contribute to the low-grade inflammatory phenomenon of metabolically unhealthy patients.

Indexed as

Th17 CellsT-Lymphocytes, RegulatoryFlow CytometryHumansLymphocyte SubsetsOverweightimmune regulationinterleukin-17lymphocytesmetabolic syndrome

Identifiers

PMID35576512
PMCPMC9307236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.